Insights on the Hepatorenal Syndrome Treatment Global Market to 2026 - Featuring Aetna, Baxter National and BioVie Among Others

MLA

“Insights on the Hepatorenal Syndrome Treatment Global Market to 2026 - Featuring Aetna, Baxter National and BioVie Among Others.” M2 Presswire, 30 Dec. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.688239944&authtype=sso&custid=ns315887.

APA

Insights on the Hepatorenal Syndrome Treatment Global Market to 2026 - Featuring Aetna, Baxter National and BioVie Among Others. (2021, December 30). M2 Presswire.

Chicago

M2 Presswire. 2021. “Insights on the Hepatorenal Syndrome Treatment Global Market to 2026 - Featuring Aetna, Baxter National and BioVie Among Others,” December 30. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.688239944&authtype=sso&custid=ns315887.